Ares Management Corporation (ARES), a global leader in alternative investments, oversees $623 billion in AUM across private credit, private equity, and real estate. This earnings report for the first quarter ended March 31, 2026, feels pivotal to me because it will test the sustainability of fee revenue growth in a still-favorable environment for private markets. With interest rates stabilizing and demand for yield-enhancing assets on the rise, ARES's success in deploying capital and attracting inflows could point to the broader health of the industry. The recent record fundraising and AUM expansion demonstrate real operational strength, which makes this release essential for anyone evaluating long-term compounding through stable management fees rather than volatile performance income.
Analysts are projecting EPS of $1.33 for Q1 2026, up from $1.09 in the year-ago quarter, drawing from estimates by 14 analysts. Revenue consensus sits at $1.11 billion from four analysts, bolstered by AUM growth and deployment activity. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry, and Zacks has EPS pegged slightly higher at $1.34.
Looking back, ARES has shown variability: Q1 2025 EPS beat ($1.09 vs. $0.94 est.), Q2 missed ($1.03 vs. $1.09), Q3 beat ($1.19 vs. $1.14), and Q4 missed ($1.45 vs. $1.69). One thing that stands out is the need to watch key metrics like FRE per share, management fees, and performance revenues, which can fluctuate with realizations. Investors will likely get updates on the fundraising pipeline and capital deployment, particularly in private credit where ARES holds a strong position. No specific company guidance came last quarter, but the full-year growth outlook remains optimistic at 27.9% EPS expansion.
Heading into earnings, sentiment around ARES strikes me as cautiously optimistic, supported by record AUM and fundraising yet checked by the Q4 2025 EPS miss that caused a nearly 7% stock drop. The shares have ridden the alternative asset boom, though volatility in performance fees remains a risk. Key factors like surprises in FRE growth or guidance could drive reactions, especially given how historical beats in core metrics have amplified moves.
One tool I rely on regularly for this kind of analysis is Tickeron’s AI Screener, an AI-powered stock and ETF discovery platform. It lets me filter thousands of stocks and ETFs using customizable criteria like industry, market cap, technical indicators, price patterns, and performance metrics, helping spot trade ideas, trending stocks, or breakout candidates far more efficiently than manual methods. From what I see, it’s a practical way to enhance my investment strategy without getting bogged down in spreadsheets.
After Q1 results, I’ll be tracking management’s full-year guidance closely, especially on fee revenue trajectory and AUM expansion. ARES's record fundraising in 2025 sets it up well for steady inflows, but sustained deployment in a competitive private markets landscape will be crucial. I’m also watching Tickeron’s AI Trend Prediction Engine for signals on momentum here.
Private credit continues as a bright spot, drawing institutional capital with its higher yields. Keep an eye on portfolio performance, unrealized marks, and cost management, since margin pressures from compensation could affect profitability.
Broader factors like interest rate paths and regulatory shifts in alternatives will shape the outlook. Upcoming catalysts might include secondary fundraising announcements and peer comparisons in asset management. For long-term insights, I focus on recurring revenue stability over one-off performance fees.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.
On October 06, 2026, the Stochastic Oscillator for ARES moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 49 instances where the indicator left the oversold zone. In 41 of the 49 cases the stock moved higher in the following days. This puts the odds of a move higher at over 84%.
The RSI Indicator entered the oversold zone -- be on the watch for ARES's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.
The Moving Average Convergence Divergence (MACD) for ARES just turned positive on October 12, 2026. Looking at past instances where ARES's MACD turned positive, the stock continued to rise in 34 of 46 cases over the following month. The odds of a continued upward trend are 74%.
Following a +1.63% 3-day Advance, the price is estimated to grow further. Considering data from situations where ARES advanced for three days, in 260 of 340 cases, the price rose further within the following month. The odds of a continued upward trend are 76%.
ARES may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
ARES moved below its 50-day moving average on September 10, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for ARES crossed bearishly below the 50-day moving average on September 17, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 10 of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 71%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ARES declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 66%.
The Aroon Indicator for ARES entered a downward trend on October 12, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of 11 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: ARES's P/B Ratio (10.730) is slightly higher than the industry average of (3.263). P/E Ratio (54.284) is within average values for comparable stocks, (27.022). Projected Growth (PEG Ratio) (0.879) is also within normal values, averaging (1.319). Dividend Yield (0.044) settles around the average of (0.081) among similar stocks. P/S Ratio (4.623) is also within normal values, averaging (15.860).
The Tickeron Price Growth Rating for this company is 61 (best 1 - 100 worst), indicating fairly steady price growth. ARES’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 69 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ARES’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock better than average.
The Tickeron Seasonality Score of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is 86 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 95 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a provider of investment advice services
Industry InvestmentManagers